Flanagan W. Michael bought RNA
September 11, 2025 · Form 4 insider transaction
Flanagan W. Michael bought 20,000 shares of Atrium Therapeutics, Inc. at $14.22 per share, a transaction worth $284.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$14.22
Total value
$284.4K
InsiderFlanagan W. Michael
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 11, 2025
Filing dateSeptember 12, 2025
Shares owned after100,195
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The exercise and sales reported in this report were effected pursuant to a Rule 10b5-1 trading plan previously adopted on June 12, 2024 by the Reporting Person.